ACUTA CAPITAL PARTNERS, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$938,734
-4.4%
153,6390.0%0.69%
+14.6%
Q4 2022$981,753
-33.3%
153,6390.0%0.60%
-4.7%
Q3 2022$1,472,000
-13.6%
153,639
-0.5%
0.63%
-33.2%
Q2 2022$1,704,000
-13.9%
154,356
+29.9%
0.95%
+2.6%
Q1 2022$1,979,000
-42.4%
118,856
-34.0%
0.92%
-35.9%
Q4 2021$3,436,000
-62.8%
179,995
-51.9%
1.44%
-55.7%
Q3 2021$9,235,000
+137.4%
374,495
+150.5%
3.26%
+109.5%
Q2 2021$3,890,000
+25.9%
149,495
+53.2%
1.56%
+39.6%
Q1 2021$3,089,000
-59.6%
97,574
-40.8%
1.11%
-46.5%
Q4 2020$7,647,000
-26.3%
164,800
-47.7%
2.08%
-26.1%
Q3 2020$10,370,000
-36.0%
315,000
-46.6%
2.82%
-39.8%
Q2 2020$16,196,000
+35.4%
590,000
+47.7%
4.68%
-19.3%
Q1 2020$11,959,000
-34.2%
399,500
-39.1%
5.80%
+28.8%
Q4 2019$18,172,000
+37.2%
656,500
-9.8%
4.50%
-52.9%
Q3 2019$13,241,000
-77.7%
727,500
-70.0%
9.56%
-54.8%
Q2 2019$59,503,000
+112.5%
2,426,701
-17.6%
21.16%
+58.9%
Q1 2019$27,999,000
+4.8%
2,944,201
-2.5%
13.31%
-34.7%
Q4 2018$26,720,000
+6.9%
3,019,201
+35.8%
20.38%
+128.5%
Q3 2018$25,005,000
-53.7%
2,222,701
-47.3%
8.92%
-7.1%
Q2 2018$53,952,000
-28.5%
4,215,000
-5.6%
9.60%
-22.0%
Q1 2018$75,430,000
+141.6%
4,463,300
+14.4%
12.32%
+109.0%
Q4 2017$31,224,000
+17.4%
3,903,000
+13.7%
5.90%
+23.7%
Q3 2017$26,597,000
-3.2%
3,431,809
-8.2%
4.77%
-38.0%
Q2 2017$27,482,0003,739,0447.69%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders